Tuesday, January, 28, 2020 02:08:35

Aquestive receives the FDA response regarding citizen petition

Aquestive Therapeutics, a renowned pharmaceutical company working towards developing and marketing various products for unmet medical demands of patients, reportedly announced that the U.S. FDA (Food and Drug Administration) sent a response letter to the company denying Aquestive’s Citizen’s Petition. The FDA received this petition …

Incyte announces results of pivotal Phase 3 GRAVITAS study for GVHD

Incyte, a renowned American biopharmaceutical company reportedly announced the results of Phase 3 GRAVITAS-301 study evaluating itacitinib together with corticosteroids in patients suffering from treatment-naïve acute GVHD (graft-versus-host disease). The results did not reach the primary endpoint of improving ORR (overall response rate) at Day …